Zoono Group are leading experts in antimicrobial protection, listed on the Australian Stock Exchange (ASX:ZNO).
Zoono specialises in the development, manufacture and global distribution of a unique range of long-lasting and environmentally friendly antimicrobial solutions.
Over the past 5 years, Zoono has developed a suite of proven products that enable our customer’s partners and distributors to realise and maximise both revenue producing and commercial opportunities.
Zoono Group has developed, and owns, a wealth of intellectual property based around the ‘Zoono Molecule’. A unique, antimicrobial technology that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mould. It has proven efficacy and longevity, it does not leach and cannot diminish in strength.
Today, Zoono Group has established a global network of customers and distributors that are spread across 42 countries and territories.
As the market leader in its field, Zoono Group continues to develop new products and industry applications via a strong base of scientific, technical and training support.
We’re the leaders in a technological shift in antimicrobial technologies. Zoono’s unique technology is unlike anything else available.
Built on a strong foundation of research, Zoono conforms to regulations from around the world and has passed PAS 2424, EN13697, EN1276 and EN1650 amongst many more antimicrobial efficacy tests.
Zoono is dedicated to providing a range of highly effective antimicrobial products.
Zoono products don’t contain harmful chemicals, they’re water-based and use a physical kill which eliminates the need for dangerous chemicals.
A true technological revolution.
Zoono is an innovative new version of an active which has been trusted by health professionals for decades.